| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.4 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |